Fate Therapeutics board sets annual say-on-pay votes after stockholder advisory approval

FATE THERAPEUTICS INC

Stockholders approved advisory vote on executive compensation every one year.
Board determined to hold non-binding say-on-pay votes annually.
Next frequency vote required no later than 2031 annual meeting.
No other changes from original May 30, 2025 8-K reported.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.